Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F

Overview of attention for article published in Frontiers in immunology, August 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 91 Dimensions

Readers on

mendeley: 92 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 836 followers.

@SnupSnus @BayAreaBiotechI See table 4. 160x diff against 17A neutralization potency , 30x+ affinity https://t.co/pX0xlsBEc9

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.